Trial Profile
A Phase II trial of OC201 for Glaucoma candidates.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Dorzolamide (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- 31 Aug 2016 New trial record